 Mary Knowles
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| TRPM Cation Channels | 4 | 2013 | 67 | 0.800 |
Why?
| | Listeria monocytogenes | 1 | 2011 | 111 | 0.350 |
Why?
| | Immunity, Innate | 2 | 2013 | 723 | 0.330 |
Why?
| | Listeriosis | 2 | 2013 | 61 | 0.200 |
Why?
| | Membrane Proteins | 4 | 2013 | 1019 | 0.180 |
Why?
| | Cytokines | 4 | 2013 | 1843 | 0.140 |
Why?
| | Macrophages | 2 | 2011 | 1267 | 0.120 |
Why?
| | Ion Channels | 2 | 2004 | 124 | 0.110 |
Why?
| | Oxidative Stress | 2 | 2013 | 1086 | 0.110 |
Why?
| | Antigens, Ly | 1 | 2013 | 45 | 0.110 |
Why?
| | Hemiterpenes | 2 | 2002 | 11 | 0.100 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 2 | 2002 | 97 | 0.100 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2011 | 17 | 0.100 |
Why?
| | Interleukin-12 Receptor beta 2 Subunit | 1 | 2011 | 2 | 0.100 |
Why?
| | Antigens, Bacterial | 2 | 2002 | 112 | 0.100 |
Why?
| | Cyclic GMP | 1 | 2011 | 78 | 0.100 |
Why?
| | Receptors, Interferon | 1 | 2011 | 47 | 0.090 |
Why?
| | Mice, Knockout | 3 | 2013 | 2586 | 0.090 |
Why?
| | Interleukin-12 | 1 | 2011 | 110 | 0.090 |
Why?
| | Cyclic AMP | 1 | 2011 | 226 | 0.090 |
Why?
| | Interferon Type I | 1 | 2011 | 128 | 0.090 |
Why?
| | Monocytes | 1 | 2013 | 503 | 0.090 |
Why?
| | Adjuvants, Immunologic | 1 | 2011 | 206 | 0.090 |
Why?
| | T-Lymphocyte Subsets | 2 | 2002 | 383 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2013 | 436 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2013 | 4718 | 0.080 |
Why?
| | Cell Movement | 1 | 2013 | 866 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2011 | 1237 | 0.080 |
Why?
| | Interferon-gamma | 1 | 2011 | 724 | 0.070 |
Why?
| | Animals | 7 | 2013 | 31884 | 0.070 |
Why?
| | Neutrophils | 1 | 2011 | 1163 | 0.060 |
Why?
| | Neurons | 1 | 2013 | 1285 | 0.060 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2004 | 7 | 0.060 |
Why?
| | Ion Channel Gating | 1 | 2004 | 83 | 0.060 |
Why?
| | Organophosphorus Compounds | 2 | 2002 | 72 | 0.060 |
Why?
| | Immune System | 1 | 2004 | 172 | 0.050 |
Why?
| | Antigens, CD1 | 1 | 2003 | 57 | 0.050 |
Why?
| | Inflammation | 1 | 2013 | 2485 | 0.050 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2003 | 50 | 0.050 |
Why?
| | Mice | 4 | 2013 | 14934 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 286 | 0.050 |
Why?
| | DNA Fragmentation | 1 | 2001 | 47 | 0.050 |
Why?
| | Curcumin | 1 | 2001 | 29 | 0.050 |
Why?
| | Lymphocyte Activation | 2 | 2002 | 1042 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2002 | 275 | 0.050 |
Why?
| | Spinal Cord | 1 | 2003 | 349 | 0.040 |
Why?
| | Mitochondria | 1 | 2004 | 750 | 0.040 |
Why?
| | Potassium Channels | 1 | 1999 | 121 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 299 | 0.040 |
Why?
| | Central Nervous System | 1 | 1999 | 239 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 1999 | 799 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 76 | 0.030 |
Why?
| | Cell Line | 2 | 2011 | 2645 | 0.030 |
Why?
| | Apoptosis | 1 | 2001 | 2368 | 0.030 |
Why?
| | Signal Transduction | 1 | 2004 | 4527 | 0.020 |
Why?
| | Brain | 1 | 2003 | 2378 | 0.020 |
Why?
| | Spleen | 1 | 2013 | 486 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2013 | 3897 | 0.020 |
Why?
| | Phagocytes | 1 | 2011 | 90 | 0.020 |
Why?
| | Molecular Weight | 2 | 2001 | 331 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2013 | 295 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2011 | 219 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 928 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 796 | 0.020 |
Why?
| | Calcium | 2 | 2004 | 1104 | 0.020 |
Why?
| | Phosphorylation | 2 | 2002 | 1574 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 1956 | 0.020 |
Why?
| | Male | 2 | 2011 | 55811 | 0.020 |
Why?
| | Humans | 5 | 2013 | 115219 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2003 | 1635 | 0.020 |
Why?
| | Female | 1 | 2011 | 59717 | 0.020 |
Why?
| | Liver | 1 | 2013 | 1688 | 0.020 |
Why?
| | Reactive Nitrogen Species | 1 | 2004 | 21 | 0.020 |
Why?
| | Pyrophosphatases | 1 | 2004 | 22 | 0.020 |
Why?
| | Niacinamide | 1 | 2004 | 62 | 0.010 |
Why?
| | Oxidants | 1 | 2004 | 112 | 0.010 |
Why?
| | Magnesium | 1 | 2004 | 145 | 0.010 |
Why?
| | Calcium Channels | 1 | 2004 | 146 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3547 | 0.010 |
Why?
| | Cation Transport Proteins | 1 | 2004 | 123 | 0.010 |
Why?
| | Protein Kinase C-theta | 1 | 2002 | 3 | 0.010 |
Why?
| | Acetophenones | 1 | 2002 | 14 | 0.010 |
Why?
| | Protein Kinase C beta | 1 | 2002 | 24 | 0.010 |
Why?
| | Benzopyrans | 1 | 2002 | 25 | 0.010 |
Why?
| | Guinea Pigs | 1 | 2003 | 149 | 0.010 |
Why?
| | Protein Kinase C-alpha | 1 | 2002 | 41 | 0.010 |
Why?
| | Carbazoles | 1 | 2002 | 80 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 798 | 0.010 |
Why?
| | Protein Kinases | 1 | 2004 | 307 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2004 | 536 | 0.010 |
Why?
| | Protein Kinase C-delta | 1 | 2002 | 70 | 0.010 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2001 | 25 | 0.010 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2001 | 17 | 0.010 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2001 | 12 | 0.010 |
Why?
| | Annexin A5 | 1 | 2001 | 22 | 0.010 |
Why?
| | Cycloheximide | 1 | 2001 | 55 | 0.010 |
Why?
| | Chemokine CCL4 | 1 | 2001 | 21 | 0.010 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2001 | 22 | 0.010 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2001 | 45 | 0.010 |
Why?
| | Chemokine CCL5 | 1 | 2001 | 45 | 0.010 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2001 | 43 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 119 | 0.010 |
Why?
| | Chemokines | 1 | 2002 | 213 | 0.010 |
Why?
| | Transcription Factor AP-1 | 1 | 2001 | 80 | 0.010 |
Why?
| | Interleukin-15 | 1 | 2001 | 75 | 0.010 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2003 | 353 | 0.010 |
Why?
| | Astrocytes | 1 | 2003 | 162 | 0.010 |
Why?
| | Protein Transport | 1 | 2002 | 398 | 0.010 |
Why?
| | Microglia | 1 | 2003 | 202 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 759 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2004 | 1990 | 0.010 |
Why?
| | Caspase 3 | 1 | 2001 | 237 | 0.010 |
Why?
| | Caspases | 1 | 2001 | 245 | 0.010 |
Why?
| | Indoles | 1 | 2002 | 306 | 0.010 |
Why?
| | Interleukin-2 | 1 | 2001 | 415 | 0.010 |
Why?
| | Kv1.3 Potassium Channel | 1 | 1999 | 1 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2797 | 0.010 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 1999 | 9 | 0.010 |
Why?
| | Immune Sera | 1 | 1999 | 79 | 0.010 |
Why?
| | Models, Molecular | 1 | 2004 | 1379 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 812 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 791 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2001 | 1084 | 0.010 |
Why?
| | NF-kappa B | 1 | 2001 | 637 | 0.010 |
Why?
| | Blotting, Western | 1 | 1999 | 1150 | 0.010 |
Why?
| | Cell Nucleus | 1 | 1999 | 556 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2001 | 1138 | 0.010 |
Why?
| | Age Factors | 1 | 2003 | 2900 | 0.010 |
Why?
| | Transcription Factors | 1 | 2002 | 1531 | 0.010 |
Why?
| | Mutation | 1 | 2004 | 3350 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2001 | 1882 | 0.010 |
Why?
| | Aging | 1 | 1999 | 1624 | 0.010 |
Why?
| | Time Factors | 1 | 1999 | 6157 | 0.010 |
Why?
| | Adult | 1 | 2001 | 30708 | 0.000 |
Why?
|
|
Knowles's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|